We therefore proceeded to examine how the abolishment of senescence pathways would affect the activity of MMP2 and MMP9 in murine placentas of the WT and the Cdkn2a−/−;p53−/− genotypes, as well as in human placenta complicated by IUGR. The gene discussed is MMP2; the disease is fetal growth restriction.